The US may be in Thanksgiving mode, but companies in other parts of the world continue to come forward with venture capital investment news, including China's Alphamab Oncology with a $100m Series A round.
Suzhou-based Alphamab said on Nov. 16 that the proceeds will fund global clinical development of its cancer drug pipeline, including...